Immunomet Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.immunomet.com
Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- ImmunoMet Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03272256
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Yonsei University Severance Hospital, Seoul, Korea, Republic of